Commentary|Videos|December 9, 2025

2025 Veeva R&D and Quality Summit: Advancing Site Efficiency and Collaboration in the Next Era of Clinical Trials

Gain insights into the operational challenges facing clinical research sites today, learn what sponsors and CROs can do to reduce burden, and explore how evolving collaboration models and technology will shape clinical trials over the next five years.

Sponsored by Veeva

In this video, Nancy Cleverley, Senior Vice President, Operations Management, AMR Clinical, provides an overview of AMR’s 30-year history and its 30-site network, then discusses the biggest opportunities to improve site operations, how sponsors and CROs can better support both sites and patients amid rising complexity, and the steps sponsors can take to enable easier data sharing, real-time collaboration, and more efficient study execution in the years ahead.

Watch and learn more:

  • Where the greatest opportunities lie to strengthen site operations
  • What sponsors and CROs can do to reduce burden and support a better participant experience
  • How sponsors can enable easier data sharing and real-time collaboration with sites
  • What clinical trials may look like in the next three to five years and how execution models are expected to evolve

Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.